ArticleCancers2021

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).

Simon Leonhard April-Monn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.